BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 15276773)

  • 1. P-Glycoprotein Activity at Diagnosis Does Not Predict Therapy Outcome and Survival in Canine B-Cell Lymphoma.
    Dékay V; Karai E; Füredi A; Szebényi K; Szakács G; Vajdovich P
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional-Vincristine Sulfate vs. Modified Protocol of Vincristine Sulfate and L-Asparaginase in Canine Transmissible Venereal Tumor.
    Setthawongsin C; Teewasutrakul P; Tangkawattana S; Techangamsuwan S; Rungsipipat A
    Front Vet Sci; 2019; 6():300. PubMed ID: 31620453
    [No Abstract]   [Full Text] [Related]  

  • 3.
    Setthawongsin C; Tangkawattana S; Rungsipipat A; Techangamsuwan S
    Front Vet Sci; 2019; 6():104. PubMed ID: 31024941
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma.
    Zandvliet M; Teske E
    Vet Sci; 2015 Aug; 2(3):150-184. PubMed ID: 29061939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction.
    Yamazaki J; Baba K; Goto-Koshino Y; Setoguchi-Mukai A; Fujino Y; Ohno K; Tsujimoto H
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):321-31. PubMed ID: 18977540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
    Klopfleisch R; Gruber AD
    J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the high mobility group A1 (HMGA1) and A2 (HMGA2) genes in canine lymphoma: analysis of 23 cases and comparison to control cases.
    Joetzke AE; Sterenczak KA; Eberle N; Wagner S; Soller JT; Nolte I; Bullerdiek J; Murua Escobar H; Simon D
    Vet Comp Oncol; 2010 Jun; 8(2):87-95. PubMed ID: 20579321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the PTEN tumor suppressor gene in malignant mammary gland tumors of dogs.
    Kanae Y; Endoh D; Yokota H; Taniyama H; Hayashi M
    Am J Vet Res; 2006 Jan; 67(1):127-33. PubMed ID: 16426222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of connexins in normal and neoplastic canine bone tissue.
    Sanches DS; Pires CG; Fukumasu H; Cogliati B; Matsuzaki P; Chaible LM; Torres LN; Ferrigno CR; Dagli ML
    Vet Pathol; 2009 Sep; 46(5):846-59. PubMed ID: 19429987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative PCR in the diagnosis of Leishmania].
    Mortarino M; Franceschi A; Mancianti F; Bazzocchi C; Genchi C; Bandi C
    Parassitologia; 2004 Jun; 46(1-2):163-7. PubMed ID: 15305709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of MDR-1 gene expression in canine tissues by real-time reverse transcription quantitative polymerase chain reaction.
    Culmsee K; Gruber AD; von Samson-Himmelstjerna G; Nolte I
    Res Vet Sci; 2004 Dec; 77(3):223-9. PubMed ID: 15276773
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.